Skip to main content

Table 3 Estimated Percentage of BMS Patients Likely to Receive DES by Year Following DES Approval

From: Changing treatment patterns for coronary artery revascularization in Canada: the projected impact of drug eluting stents

 

Mean

Median

Min

Max

# of Panel Members Responding

% of Bare Metal Stent Patients Receiving DES, 1st Year Following Approval

all patients

24.0%

22.5%

5.1%

65.0%

10

all patients with single-vessel

18.8%

12.6%

5.0%

50.0%

8

all patients with multi-vessel

32.9%

25.0%

5.0%

80.0%

6

% of Bare Metal Stent Patients Receiving DES, 2nd Year Following Approval

all patients

36.6%

40.0%

10.2%

65.0%

10

all patients with single-vessel

28.4%

30.4%

10.0%

50.0%

9

all patients with multi-vessel

43.9%

40.0%

5.1%

100.0%

8

% of Bare Metal Stent Patients Receiving DES, 3rd Year Following Approval

all patients

57.1%

60.0%

20.5%

80.0%

10

all patients with single-vessel

53.5%

60.0%

20.0%

80.9%

9

all patients with multi-vessel

61.2%

65.0%

10.3%

100.0%

8

% of Bare Metal Stent Patients Receiving DES, 4th Year Following Approval

all patients

76.7%

80.0%

50.8%

91.0%

10

all patients with single-vessel

69.6%

80.0%

30.0%

91.0%

9

all patients with multi-vessel

85.0%

80.0%

80.0%

100.0%

7

% of Bare Metal Stent Patients Receiving DES, 5th Year Following Approval

all patients

85.0%

90.0%

49.0%

100.0%

10

all patients with single-vessel

81.7%

90.0%

49.0%

100.0%

9

all patients with multi-vessel

88.4%

90.0%

60.0%

100.0%

8